Fursultiamine

DB08966ApprovedSmall molecule

Compound used for therapy of thiamine deficiency. It has also been suggested for several non-deficiency disorders but has not yet proven useful. Fursultiamine is a vitamin B1 derivative.

Chemical structure of Fursultiamine
Mechanism
Curator reviewed
Formula / weight
C17H26N4O3S2 · 398.543 g/mol (avg)
Also known as
Thiamin tetrahydrofurfuryl disulfide · Thiamine tetrahydrofurfuryl disulfide · TTFD

Resolves to

Compound
UNII05J61265PXCAS804-30-8ChEMBLCHEMBL1740659ChEBI135636PubChem3002119
Clinical / RWD
RxNorm4604
Structure
InChIKeyJTLXCMOFVBXEKD-FOWTUZBSSA-NSMILESC\C(N(CC1=C(N)N=C(C)N=C1)C=O)=C(\CCO)SSCC1CCCO1
Targets
Q9NP59SLC40A1P81172HAMPQ9NZQ7CD274

What you can answer from here — as of September 13, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
9Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
6Marketed productsAcross 5 countries and 4 labellers
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Fursultiamine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In